Fieldstone Bio recently raised $5 million in seed funding.
Category: synthetic biology
Biotech & Health, Climate, Colossal Biosciences, CRISPR, de-extinction tech, Global Security News, Startups, synthetic biology
Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation?
On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf. These are creatures that have been extinct for more than 12,000 years made famous by the HBO show Game of Thrones. These white, fluffy animals live on a 2,000-acre preserve in a location so secretive that journalists, including…
Biotech & Health, Climate, Colossal Biosciences, CRISPR, de-extinction tech, Global IT News, Global Security News, Startups, synthetic biology
Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths
Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it. © 2024 TechCrunch. All rights reserved. For personal use only.
Climate, Climate Capital, early stage investors, Exclusive, Global IT News, Global Security News, Juniper, synthetic biology, Venture
Juniper Ventures spins out of Climate Capital to invest in synthetic biology for the climate
The first Juniper fund is $10.6 million and is oversubscribed. © 2024 TechCrunch. All rights reserved. For personal use only.